You just read:

Clinical Cancer Research Publishes Study Demonstrating Clinically Meaningful and Statistically Significant Prognostic Improvement by the Breast Cancer Index(SM) Over Oncotype DX® in Early-Stage, Estrogen Receptor-Positive, Lymph Node-Negative Breast Cancer Patients

News provided by

Biotheranostics, Inc.

02 Jun, 2016, 17:17 ET